AI assistant
NEOGENOMICS INC — Director's Dealing 2025
Sep 3, 2025
32227_dirs_2025-09-03_a57331d0-623e-4c29-8704-5557abdf0fca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-09-01
Reporting Person: Olivo Alicia C (EVP, GC & Business Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-01 | Common Stock | F | 1666 | — | Disposed | 47940 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $19.12 | 2026-09-30 | Common Stock (1046) | 1046 | Direct |
| Stock Option (Right to Buy) | $27.34 | 2027-05-01 | Common Stock (1024) | 1024 | Direct |
| Stock Option (Right to Buy) | $48.99 | 2028-05-01 | Common Stock (516) | 516 | Direct |
| Stock Option (Right to Buy) | $46.10 | 2028-08-01 | Common Stock (1117) | 1117 | Direct |
| Stock Option (Right to Buy) | $9.45 | 2029-05-01 | Common Stock (22222) | 22222 | Direct |
| Stock Option (Right to Buy) | $10.05 | 2029-09-01 | Common Stock (55332) | 55332 | Direct |
| Stock Option (Right to Buy) | $19.65 | 2030-05-11 | Common Stock (36508) | 36508 | Direct |
| Restricted Stock Unit | $0 | Common Stock (6503) | 6503 | Direct | |
| Performance Stock Unit | $0 | Common Stock (19508) | 19508 | Direct | |
| Stock Option (Right to Buy) | $16.45 | 2034-02-23 | Common Stock (42344) | 42344 | Direct |
| Restricted Stock Unit | $0 | Common Stock (59382) | 59382 | Direct | |
| Performance Stock Unit | $0 | Common Stock (25330) | 25330 | Direct | |
| Restricted Stock Unit | $0 | Common Stock (16886) | 16886 | Direct | |
| Stock Option (Right to Buy) | $13.05 | 2035-02-21 | Common Stock (107450) | 107450 | Direct |
| Restricted Stock Unit | $0 | Common Stock (63238) | 63238 | Direct |
Footnotes
F1: Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the September 1, 2025 vesting of restricted stock.
F2: On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F3: On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4: On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5: On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6: On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F7: On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F8: On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F9: On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F10: Once vested, the shares of common stock are not subject to expiration.
F11: On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
F12: On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F13: On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F14: On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F15: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
F16: On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F17: On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.